4

HPV16 E6 + HPV18 E6 Antibody, Cy5.5 Conjugated

Details

HPV16 E6 + HPV18 E6 Antibody, Cy5.5 Conjugated

Name

bs-1719R-Cy5.5

Catalog Number

350 EUR

Price

0.1ml

Size

More information

Antigen background

Human Papilloma virus (HPV) is responsible for the development of type and tissue specific papilloma in the oral cavity and in the larynx. In the skin papilloma virus can cause different types of warts and in the ano-genital region it is associated with condyloma or carcinoma. HPV types 16 and 18 seem to be responsible for the development of some carcinoma like cervical carcinoma.

Properties

If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.Cy5 antibodies are excited by the 650-nanometer wave of an argon laser and detected at a 670-nanometer captor.

Storage conditions

Keep the antibody in an aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store refrigerated at 2 to 8 degrees Celcius for up to 1 year.

Specificity

This is a highly specific antibody against HPV16 E6 + HPV18 E6. This antibody may also detect HPV45 E6, HPV68 E6, HPV39 E6, and HPV35 E6

Conjugated

These antibodies are excite for emission at 678nm and detected at a 694 nm wavelengths.

Source

KLH conjugated synthetic peptides from HPV16 E6 + HPV18 E6

Long name

HPV16 E6 + HPV18 E6 Polyclonal Antibody, Cy5.5 Conjugated

Purification method

This antibody was purified via Protein A.

Host Organism

Rabbit (Oryctolagus cuniculus)

Category

Conjugated Primary Antibodies

Recommended dilutions

IF(IHC-P)(1:50-200)

Target Antigen

HPV16 E6 + HPV18 E6

Clone

Polyclonal antibody

Gene ID number

1489078, 1489088

Synonyms

Protein E6; E6

Swiss Prot

P03126, P06463

Crossreactive species details

HPV16/HPV18

Concentration

1ug per 1ul

Excitation Emission

675nm/694nm

Additional conjugation

Cy5.5,Cy5.5

Clonality

Polyclonal

Modification

Unmodified

Tested applications

IF(IHC-P)

French translation

anticorps

Crossreactivity

Virus

Conjugation

Cy5.5

Modification site

None

Back to top